Pharmacology Flashcards

1
Q

Control of bronchiole smooth muscle

A

sympathetic/ para sympathetic control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Sympathetic control function

A

bronchodilation
opens airways
greater air influx - fight/ flight

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Sympathetic control mechanism

A

Short pre (ACh + nicotinic), long post, noradrenaline
Innervates adrenal gland
- secretes adrenaline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

adrenaline + Beta 2 receptor

A

beta 2 receptor activated
- Gs alpha sub unit activates Adenylyl Cyclase
- catalyses ATP -> cAMP
- cAMP activates Protein Kinase A
phosphorylates MLCK (inhibits) + myosin phosphatase (stimulates)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Phosphodiesterase

A

enzyme

  • catalyses cAMP -> 5’AMP
  • inhibits PKA activity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Parasympathetic control function

A

bronchoconstriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Parasympathetic control mechanism

A

long pre (ACh, nicotinic) short post (ACh - muscarinic M3 receptor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

M3 muscarinic receptor agonist

A
M3 receptor agonist 
- activates Gq/11 alpha sub unit 
- Activates Phosphlipase C 
- catalyses PIP2 -> IP3 
- IP3 activates IP3 receptor 
Ca2+ influx 
- voltage gated Ca2+ 
- Ca2+ gated 2+ channels 
Ca2+ + calmodulin 
activated MLCK 
MLC phosphorylated 
myosin heads bind to actin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

SABAs

A

short acting Beta 2 agonists

  • salbutamol
  • innervate Beta 2 receptors
  • bronchodilation
  • prn
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

LABAs

A
long acting beta 2 agonists 
- formoterol + salmeterol 
innervate beta 2 receptors 
bronchodilation
twice daily 
- prophylactic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

SAMAs

A

short acting muscarinic antagonists
- antagonise M3 receptors
prevent bronchoconstriction
- Ipratropium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

LAMAs

A

Long acting muscarinic antagonists

  • antagonise M3 receptors
  • prevent bronchoconstriction
  • Tiotropium
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Examples of inhaled glucocorticoids

A

Beclometasone dipropionate (BDP), Budesonide + fluticasone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Mechanism of corticosteroids

A

Lipophilic
- bind to GR alpha receptors in cytoplasm
- form homomers
increased transcription of anti-inflammatory genes
decreased transcription of inflammatory proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Glucocorticoid steroid effect

A
  • Decreased: cytokine production
    mast cell + eosinophil influx
    activation of CD4+
    Stabilises airway
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Oral glucocorticoid example

A

prednisolone

17
Q

Features of prednisolone

A
  • Good when airway very obstructed, low uptake of inhaled
  • Low therapeutic ratio
    2 week trial -> inhaled
18
Q

Cysteinyl Leukotriene Receptor Antagonists

A
  • Montelukast + Zafirlukast
  • Prevent bindings of leukotrienes
    anti inflammatory effect
  • bronchodilation
    Prevents oedema + mucous hypersecretion
    prevents eosinophil influx
19
Q

Cromones

A

Supress histamine secretion
- cromoglicate
poor efficacy
asthma only

20
Q

Methyl xanthines

A

Theophylline
- inhibit phosphodiesterase
increased PKA activity

21
Q

Anti IgE treatment

A
Omalizumab 
- prevents mast cell activation 
- decreased histamine, IL 5 + IL13 secretion 
very expensive 
- severe + persistent asthma only
22
Q

Anti IL 5

A

Mepolizumab
Blocks effect of IL-5
prevents eosinophil influx
- expensive

23
Q

Anti IL4 alpha

A

Dupilumab
prevents IL-4 + IL-13 binding
- decreased eosinophil influx, IgE production airway hypersensitivity

24
Q

Mucolytics

A

Carbocisteine
- COPD only
decrease mucous viscosity

25
Q

Inhalers pros

A
  • delivery to tissue
  • Rapid absorption
  • Lower dose required, less side effects
  • Good distribution to target tissue
  • spacers used to make easier
26
Q

Inhaler cons

A
  • Hard to use
    incorrect inhalation, ineffective treatment
  • compliance
27
Q

spacers

A

reduce speed + particle size
allow drug to be distributed to smallest bronchioles
- greater effect

28
Q

pros/ cons oral medication

A

greater systemic conc., more side effects

taken when airway is compromised